Smith & Nephew completes acquisition of tissue regeneration developer Rotation Medical Inc
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces it has completed the acquisition of…
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces it has completed the acquisition of…
The Company has today cancelled 309,247 of its Ordinary Shares of US 20¢ each ("Shares") previously held in Treasury. Th…
The Company will now commence its Quarterly Buy Back programme of 309,247 of its Ordinary shares of US 20¢ each through…
The Company today purchased 450,000 of its Ordinary Shares of US 20¢ each through J.P. Morgan Securities, in accordance…
The Company today purchased 300,000 of its Ordinary Shares of US 20¢ each through Merrill Lynch International, in accord…
The Company has today cancelled 1,570,000 of its Ordinary Shares of US 20¢ each ("Shares") previously held in Treasury.…
The Company today purchased 200,000 of its Ordinary Shares of US 20¢ each through Merrill Lynch International, in accord…
The Company today purchased 250,000 of its Ordinary Shares of US 20¢ each through Merrill Lynch International, in accord…
The Company today purchased 250,000 of its Ordinary Shares of US 20¢ each through Merrill Lynch International, in accord…
Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that it has signed a definitive…